awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38199723-2AD74EAC-337E-473B-88C9-D5B33E3BC26E
Q38199723-2AD74EAC-337E-473B-88C9-D5B33E3BC26E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38199723-2AD74EAC-337E-473B-88C9-D5B33E3BC26E
Brief overview of selected approaches in targeting pancreatic adenocarcinoma.
P2860
Q38199723-2AD74EAC-337E-473B-88C9-D5B33E3BC26E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38199723-2AD74EAC-337E-473B-88C9-D5B33E3BC26E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
63ff94e28e9c7e2732ad3cdaf06b9b9f9eb75983
P2860
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer